Revolution Medicines (RVMD) Share-based Compensation (IS) (2024 - 2026)
Revolution Medicines' Share-based Compensation (IS) was $67 million in Q2 2026, up 132.4% from $28.83 million a year earlier but down 23.3% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Share-based Compensation (IS) was $218.77 million through Jun 30, 2026, up 125.2% year-over-year; for FY2025, it came in at $118.39 million, up 49.5% from FY2024.
- Share-based Compensation (IS) has now increased for three consecutive years, with a three-year compound annual growth rate of 56.0% (FY2022 to FY2025).
- In earlier years, Share-based Compensation (IS) was $79.2 million in FY2024 (+28.2%), $61.77 million in FY2023 (+98.0%) and $31.2 million in FY2022.
- Quarterly Share-based Compensation (IS) has moved between $16.21 million (Q1 2024) and $87.3 million (Q1 2026) over five years.
- Compared with a year earlier, Share-based Compensation (IS) has increased for six straight quarters, with growth averaging 96.5% over the last six quarters.
- Per Business Quant data, RVMD's Share-based Compensation (IS) in the three quarters before Q2 2026 was $87.3 million (Q1 2026), $33.7 million (Q4 2025) and $30.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 67.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.00 Mn |
| Mar 31, 2026 | 87.30 Mn |
| Dec 31, 2025 | 33.70 Mn |
| Sep 30, 2025 | 30.78 Mn |
| Jun 30, 2025 | 28.83 Mn |
| Mar 31, 2025 | 25.08 Mn |
| Dec 31, 2024 | 22.44 Mn |
| Sep 30, 2024 | 20.78 Mn |
| Jun 30, 2024 | 19.78 Mn |
| Mar 31, 2024 | 16.21 Mn |
API Access
Revolution Medicines Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();